Electrophoresis of nucleic acid fragments
AssigneeAmersham Life Science, Inc.
InventorCarl W. Fuller
Life of this patent
Estimating the term…
Abstract
A method for electrophoresis of nucleic acid fragments present in the solution which contains an amount, e.g., 0.2% or more, of a reagent, e.g., glycerol, dithiolthreitol (DTT) and trehalose or other sugars, which interact to form a complex with borate or boric acid. The method includes applying the solution to an electrophoretic gel and electrophoresing those fragments into the gel in the presence of a buffer lacking boric acid, or a derivative thereof, which forms a chelate complex with the reagent and thereby causes distortion of electrophoresis of the fragments in a gel including such a buffer.
Claims2
A buffer at a pH between 7.5 and 9.5 consisting essentially of Tris and taurine in the presence of a geling agent.
A buffer at a pH between 7.5 and 9.5 consisting essentially of Tris, taurine, and EDTA in the presence of a geling agent.
Dependencies are inferred from the claim text.